Inspire Medical Systems (INSP) Financials

$73.36

$0.61 (0.84%)

As on 17-Sep-2026 15:43EDT

Market cap

$2,110 Mln

Revenue (TTM)

$899 Mln

P/E Ratio

16.1

P/B Ratio

2.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	898.74	911.98	802.80	624.80	407.86	233.39
Cost of Revenue	124.64	133.23	122.99	96.58	66.12	33.28
Gross Profit	774.11	778.76	679.82	528.22	341.74	200.12
Operating Expenses	719.98	727.80	643.74	568.49	389.33	239.97
Operating Profit (EBIT)	54.12	50.95	36.08	-40.27	-47.59	-39.85
Other Income	--	--	--	--	4.88	-0.08
Profit before Tax	69.38	65.70	58.45	-19.91	-44.27	-41.97
Provision for Tax	-65.66	-79.73	4.94	1.25	0.61	0.07
Profit after Tax (Net Income)	135.04	145.42	53.51	-21.15	-44.88	-42.04
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-44.88	-42.04

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	825.58	781.16	689.70	572.51	496.01	229.05
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	29.23	30.10	30.19	26.19	7.68	24.73
Current Liabilities	71.18	96.06	88.50	78.11	61.19	41.31
Total Liabilities	997.18	907.32	808.38	676.81	564.88	295.08

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	317.32	323.66	177.58	83.07	34.84	26.55
Current Assets	608.67	583.65	630.81	593.74	530.03	268.54
Total Assets	997.18	907.32	808.38	676.81	564.88	295.08
Total Debt*	29.09	32.16	31.79	24.85	16.41	34.10
Net Current Assets	537.49	487.60	542.31	515.63	468.85	227.23

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	116.98	130.25	24.65	11.57	-20.12
Cash Flow from Investing Activities	--	21.45	-113.12	-294.82	-19.60	29.14
Cash from Financing Activities	--	-183.45	-52.39	13.95	235.08	14.95
Net Cash Inflow / Outflow	--	--	--	--	227.05	23.95

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	4.61	4.98	1.74	-0.70	-1.49	-1.54
Cash EPS ($)	--	5.45	1.95	-0.61	-1.42	-1.49
Adjusted Book Value ($)	--	26.74	22.43	18.93	16.42	8.37
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	4.00	4.24	0.82	0.38	-0.73
Free Cash Flow per Share ($)	--	2.69	2.96	0.03	0.08	-0.91

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	18.95	8.11	-3.81	-11.57	-16.06
ROE (%)	16.81	19.77	8.48	-3.96	-12.38	-18.33
ROA (%)	14.27	16.95	7.21	-3.41	-10.44	-14.59
EBIT Margin (%)	7.33	7.22	7.28	-6.45	-10.44	-17.07
Net Margin (%)	15.03	15.95	6.67	-3.39	-10.87	-18.02
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	4.35	0.14	0.28	0.53	0.75	1.02
EBIT Growth (%)	-13.80	12.58	245.20	5.45	-6.90	27.52
Net Profit Growth (%)	154.22	171.77	352.96	52.87	-6.75	26.50
EPS Growth (%)	167.09	1.86	3.49	0.53	0.03	0.28
Book Value Growth (%)	24.18	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	16.11	18.53	106.54	-290.79	-169.54	-149.80
Price / Book Value	2.39	3.45	8.27	10.74	15.34	27.50
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	19.46	30.31	81.31	-141.93	-176.13	-158.38
Close Price ($)	44.61	92.23	185.38	203.43	251.88	230.06
High Price ($)	147.03	216.01	257.40	330.00	272.04	286.29
Low Price ($)	38.91	70.84	123.00	123.27	142.74	159.18
Market Cap ($ Cr)	2,110.46	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.04	0.05	0.04	0.03	0.15
Short term debt to equity ratio	--	0.00	0.00	--	0.00	0.04
Current Ratio	8.55	6.08	7.13	7.60	8.66	6.50
Quick Ratio	6.16	4.56	6.22	7.17	8.47	6.08
Interest Coverage	522.67	480.54	2,657.95	--	-25.40	-18.72

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	11.50	13.12	11.59	14.39	15.01	14.64
Asset Turnover	0.95	1.06	1.08	1.01	0.95	0.81
Receivable days	--	42.61	41.62	44.17	42.72	46.36
Inventory Days	--	308.99	169.29	86.55	80.43	141.09
Payable days	--	103.16	115.12	124.21	106.38	103.57
Cash Conversion Cycle	--	248.44	95.78	6.51	16.77	83.87

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.